A detailed history of Brucke Financial, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Brucke Financial, Inc. holds 2,400 shares of ABBV stock, worth $561,600. This represents 0.31% of its overall portfolio holdings.

Number of Shares
2,400
Previous 2,609 8.01%
Holding current value
$561,600
Previous $484 Million 8.06%
% of portfolio
0.31%
Previous 0.34%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025

SELL
$184.85 - $231.54 $38,633 - $48,391
-209 Reduced 8.01%
2,400 $523 Million
Q2 2025

Jul 24, 2025

BUY
$170.16 - $206.27 $6,125 - $7,425
36 Added 1.4%
2,609 $484 Million
Q1 2025

May 07, 2025

BUY
$169.2 - $216.66 $7,783 - $9,966
46 Added 1.82%
2,573 $502 Million
Q4 2024

Feb 27, 2025

BUY
$164.99 - $203.87 $416,929 - $515,179
2,527 New
2,527 $465 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $414B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Brucke Financial, Inc. Portfolio

Follow Brucke Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brucke Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brucke Financial, Inc. with notifications on news.